- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00739531
Measuring Exhaled Nitric Oxide (eNO) Using the Apieron INSIGHT System and the Aerocrine NIOX System
August 20, 2008 updated by: Apieron
Measuring the Fractional Concentration of Exhaled Nitric Oxide (eNO) Using the Apieron INSIGHT System and the Aerocrine NIOX System
Collection of quantitative data to demonstrate the accuracy (bias) and precision (repeatability) of the Apieron INSIGHT(tm) eNO Breath System as compared to the FDA cleared NIOX eNO Breath System when testing is performed by asthma patients.
Study Overview
Detailed Description
A non-randomized, prospective study of up to 150 subjects with asthma.
Patients will perform eNO testing with the Apieron INSIGHT(tm) eNO system and the NIOX eNO system at the physician's office/clinic after a short demonstration and training by a healthcare professional trained in the use of the devices.
Exhaled NO testing involves inhaling to lung capacity, and then performing a controlled exhalation into a mouthpiece connected to each of the Apieron INSIGHT(tm) and NIOX systems.
Patients will perform an eNO measurement with the Apieron INSIGHT(tm) system and with the FDA cleared NIOX system for the accuracy portion of the study.
Patients will perform 2 sequential eNO measurements on each system for the precision part of the study.
Subjects that measure eNO values over 100 ppb will be asked to repeat 2 sequential eNO measurements on each system.
Study Type
Observational
Enrollment (Anticipated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
Shreveport, Louisiana, United States, 71105
- The Asthma- Allergy Clinic& Research Center
-
-
Oregon
-
Lake Oswego, Oregon, United States, 97035
- Allergy, Asthma & Dermatology Research Center, LLC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Up to 150 asthma patients recruited from the site center's population of patients.
Description
Inclusion Criteria:
- Age 5 or older
- Pre-existing diagnosis of asthma
- Non-smoker
Exclusion Criteria:
- Chronic inflammatory lung disease other than asthma
- Medical conditions that preclude hand-eye coordination
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Asthmatics
Subjects with asthma
|
Subjects will perform a controlled breath maneuver using both the Apieron and NIOX devices.
The devices will measure nitric oxide in the subjects' exhaled breath.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
eNO using Apieron INSIGHT(tm) System and Aerocrine NIOX at 50 ml/s
Time Frame: Single point in time
|
Single point in time
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2007
Primary Completion (ACTUAL)
December 1, 2007
Study Completion (ACTUAL)
December 1, 2007
Study Registration Dates
First Submitted
August 19, 2008
First Submitted That Met QC Criteria
August 20, 2008
First Posted (ESTIMATE)
August 21, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
August 21, 2008
Last Update Submitted That Met QC Criteria
August 20, 2008
Last Verified
August 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Respiratory Tract Diseases
- Immune System Diseases
- Lung Diseases
- Hypersensitivity, Immediate
- Bronchial Diseases
- Lung Diseases, Obstructive
- Respiratory Hypersensitivity
- Hypersensitivity
- Asthma
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Vasodilator Agents
- Autonomic Agents
- Peripheral Nervous System Agents
- Protective Agents
- Bronchodilator Agents
- Anti-Asthmatic Agents
- Respiratory System Agents
- Antioxidants
- Free Radical Scavengers
- Endothelium-Dependent Relaxing Factors
- Gasotransmitters
- Nitric Oxide
Other Study ID Numbers
- CP00014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsNot yet recruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma Chronic
-
Johann Wolfgang Goethe University HospitalCompleted
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
-
Universita di VeronaCompleted
-
Forest LaboratoriesCompleted
-
Brunel UniversityKarolinska InstitutetUnknown
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia
-
Johann Wolfgang Goethe University HospitalCompletedExercise-induced AsthmaGermany
Clinical Trials on Exhaled nitric oxide (eNO)
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Imperial College LondonGlaxoSmithKlineWithdrawnHealthy Smokers | Healthy Non-smokers | Patients With Mild Asthma | Patints With COPD (GOLD II)United Kingdom
-
Catholic University of the Sacred HeartMerck Sharp & Dohme LLCCompleted
-
Imperial College LondonAstraZenecaWithdrawnChronic Obstructive Pulmonary Disease (COPD) | Age Matched Healthy Volunteers (Non-smokers)United Kingdom
-
Medical University of LodzUnknown
-
Beyond Air Inc.Recruiting
-
Imperial College LondonAstraZenecaWithdrawnCOPD Patients | Current Smokers | Healthy Non-smokersUnited Kingdom
-
Universitair Ziekenhuis BrusselVrije Universiteit BrusselCompletedChronic Obstructive Pulmonary DiseaseBelgium
-
Tomsk National Research Medical Center of the Russian...Siberian State Medical UniversityCompletedCoronavirus Infection | Pneumonia, Viral | HypoxemiaRussian Federation
-
Zhujiang HospitalCompletedCough Variant AsthmaChina